Medicine and Dentistry
Actin
10%
Acute Lymphoblastic Leukemia
17%
Adolescent
10%
Antiretroviral Therapy
23%
Body Mass Index
17%
Body Weight Change
18%
Brain Metastasis
26%
Breast Cancer
23%
Cancer Cell
12%
Case-Control Study
15%
Cervical Cancer
17%
Chemoimmunotherapy
17%
Colorectal Cancer
28%
Cross Sectional Study
20%
Cumulative Incidence
11%
Cyclophosphamide
44%
Dactinomycin
29%
Diffuse Large B-Cell Lymphoma
19%
Disease
22%
Embryonal Rhabdomyosarcoma
23%
Failure Free Survival
38%
Hazard Ratio
12%
Human Immunodeficiency Virus
29%
Immunotherapy
36%
Infection
21%
Liver Transplantation
17%
Malignant Neoplasm
74%
Medical Record
10%
Metastatic Carcinoma
41%
Mucin 4
43%
Neoplasm
21%
Oncology
96%
Overall Survival
45%
Pancreas Adenocarcinoma
35%
Pancreas Cancer
21%
Pancreas Tumor
24%
Positron Emission Tomography
17%
Positron Emission Tomography-Computed Tomography
17%
Primary Tumor
40%
Quality of Life
11%
Radiation Therapy
82%
Recurrent Disease
22%
Rhabdomyosarcoma
100%
Soft Tissue Sarcoma
52%
Stereotactic Body Radiation Therapy
17%
Surgery
17%
Survival Rate
22%
Symptom
18%
Uterine Cancer
17%
Vincristine
33%
Pharmacology, Toxicology and Pharmaceutical Science
4 Hydroxyestradiol
14%
Bacteremia
10%
Bile Acid
26%
Biological Marker
46%
Brain Metastasis
26%
Breast Cancer
13%
Cancer Incidence
10%
Case-Control Study
15%
Catechol Estrogen
13%
Chemoradiation Therapy
11%
Chemotherapy
34%
Chronic Obstructive Lung Disease
17%
Cross-Sectional Study
10%
Cyclophosphamide
48%
Dactinomycin
32%
dibenzo[a,l]pyrene
14%
Diethylstilbestrol
15%
Diffuse Large B Cell Lymphoma
10%
Disease
23%
DNA Glycosyltransferase
12%
Embryonal Rhabdomyosarcoma
20%
Failure Free Survival
36%
Heteroduplex
14%
HIV
41%
Immunotherapy
44%
Infection
26%
Lenalidomide
17%
Liver Disease
26%
Malignant Neoplasm
69%
Metastasis
18%
Mouse
21%
Mucin 4
17%
Neoplasm
24%
Neutropenia
9%
Nonhodgkin Lymphoma
17%
Normal Human
9%
Overall Survival
33%
Pancreas Adenocarcinoma
34%
Pancreas Cancer
12%
Pancreas Tumor
20%
Pig
9%
Primary Tumor
26%
Quinone Derivative
25%
Recurrent Disease
13%
Rhabdomyosarcoma
82%
Sensitive to Carcinogenesis Mouse
17%
Soft Tissue Sarcoma
44%
Survival Rate
18%
Uterine Cervix Cancer
26%
Vincristine
38%
Keyphrases
Abasic Site
10%
ACI Rats
24%
Adenocarcinoma Cells
9%
Antiretroviral Therapy
13%
Cancer Screening Uptake
8%
Chemoradiation
12%
Chemotherapy
29%
Children's Oncology Group
34%
Confidence Interval
11%
Copenhagen Rat
11%
Cyclophosphamide
16%
Dactinomycin
11%
Definitive Surgery
9%
Estradiol
14%
Estrogen
40%
Failure-free Survival
12%
Genetic Basis
17%
Genetic Determinants
9%
Geographical Factors
8%
H-Ras Gene
10%
Hazard Ratio
12%
Heteroduplex
9%
Intercross
9%
Local Control
10%
Low Risk
19%
Lycopene
17%
Mammary Cancer
10%
Mammary Gland
9%
Metabolic Syndrome
17%
Mortality Risk
10%
MUC4
26%
MUC4 mucin
9%
Multivariable
10%
National Cancer Database
25%
Nebraska
9%
Observation Tool
8%
Overall Survival
22%
Overall Survival of Patients
11%
Pancreatic Adenocarcinoma
26%
Pancreatic Ductal Adenocarcinoma
12%
Pituitary
9%
Quinones
18%
Radiation Therapy
22%
Radiotherapy
12%
Rat Strains
19%
Resource-limited Environment
17%
Rhabdomyosarcoma
24%
Skilled Care Facility
8%
Soft Tissue Sarcoma
17%
Tumor
12%